Yikang Biotechnology (Shanghai) Co., Ltd.
益方生物科技(上海)股份有限公司InventisBio Co.,LimitedAlias益方生物Alias
§01
Basic information
- Head office
- Room 210, No. 4, Lane 67, Libing Road, Shanghai Free Trade Pilot Zone, China
- Chief executive
- Wang Yaolin
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2013-01-11
- End date
§02
Websites
§03
Business
Innovative drug research and development, production, and sales (focusing on major diseases such as tumors, autoimmune diseases, and metabolic diseases)Glesorease (targeting KRAS G12C, lung cancer/pancreatic cancer treatment drug)Research pipeline of innovative drugs targeting synthetic lethal pathways, autoimmune targets, kinases, and tumor driver genesTechnology licensing and cooperation business
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| 康宁杰瑞 |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
§07
News
There is no news.
§09